 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
VACCINATION
TEST KIT
|
31
Vials $90
|
|||
| Code | Vaccine | Type | Vaccination Requirements | Possible Long Term Effects |
| VA1 | B.C.G. (Tuberculosis) | live attenuated | In UK at age 12-13 | TB, ME |
| VA2 | Cholera | killed organisms | vaccination only recommended if travelling to cholera areas across remote borders, especially overland. | severe allergic reactions to vaccine, nerve damage, mental problems |
| VA3 | D.P.T. (Diphtheria, Whooping Cough, Tetanus) | toxoids of diphtheria & tetanus; inactivated pertussis | introduced in 1957 in UK, by 1969 over 80% of children vaccinated | sudden infant death syndrome, brain damage, asthma |
| recommended regime is 4 times before age 6 and then age 14-16 years old, and then every 10 years afterwards | ||||
| VA4 | Diphtheria | inactivated bacterial toxins | introduced in 1930’s, now mainly given as DPT | |
| VA5 | Diphtheria / Tetanus | inactivated bacterial toxins | now mainly given as DPT | |
| VA6 | Encephalitis | inactivated | travel vaccination for Far East, Indian subcontinent, South East Asia | |
| VA7 | Hepatitis A | travel vaccination | ||
| VA8 | Hepatitis B | genetic engineering (yeast or plasma derived) | In New Zealand vaccination of babies introduced in 1988 and abandoned in early 1990’s following evidence of immune suppression; routinely offered to infants in US, but not in UK; compulsory in Italy | ME, arthritis, kidney disease, nerve inflammation, severe skin eruptions, eye problems |
| VA9 | HIB (Bacterial Meningitis caused by Haemophilus Influenzae type b) | introduced in US in 1985 and UK in 1992; given routinely in US at 18 months | ||
| VA10 | Influenza (various strains) 2 | killed organisms | encephalitis, neuritis, optic neuritis, vasulitis and joint problems, reversible paralysis, myelopathy, exacerbate asthma | |
| VA11 | Measles | live attenuated | first introduced in UK in 1968 and in US in 1957; banned in UK in August 1999 to force parents to use MMR | |
| VA12 | Meningitis | polysaccaride | Saudi Arabia requires immunisation for those going on pilgrimage to Mecca | |
| VA13 | MMR (Measles, Mumps and Rubella) | live attenuated | first introduced in UK in 1988 and in US in 1975 | autism, Crohn’s disease, seizures |
| VA14 | MR (Measles and Rubella) | live attenuated | ||
| VA15 | Pertussis (Whooping Cough) | killed organisms | first available in 1912; commonly available mid 1950’s; now mainly given as DPT; | brain damage, asthma |
| compensation for vaccine damage introduced in UK in 1978 | ||||
| VA16 | Pneumovax | polysaccaride | given to elderly people to prevent pneumonia a few years ago | |
| VA17 | Polio (Sabin) | attenuated live given orally | in use since mid 1960’s, prior to that the Salk polio vaccine was used | weight gain, Guillain-Barre syndrome, ME |
| VA18 | Polio (Salk) | killed organisms given intramuscularly | polio vaccine first introduced in 1952/53 in US and 1956 in UK; the Sabin polio vaccine used in America and England since 1960’s; Finland, Sweden and Netherlands use this polio vaccine | |
| VA19 | Rabies | killed organisms | travel vaccination for those exposed to an unusual risk of infection e.g. taking long journeys in the bush | |
| VA20 | Rubella (German Measles) | live | rubella during earlier pregnancy can result in damage to unborn child (congenital Rubella Syndrome) | arthritis, polneuralgia, chronic fatigue syndrome |
| VA21 | Smallpox | introduced in England in 1840 and made compulsory in 1853; it is now believed that smallpox has been eradicated so immunisation is no longer required; USA vaccination programme stopped in 1972, re-introduced for selected categories of people in 2003 | ||
| VA22 | TAB (Paratyphoid) | killed organisms | ||
| VA23 | Tetanus | inactivated bacterial toxins | now mainly given as DPT | |
| VA24 | Typhoid | killed organisms | ||
| VA25 | Yellow Fever | live attenuated | ||
| VA26 | Meningitis C | First used in UK in clinical trials in 1994; vaccination programme started in 1999 in UK, and from 2000 in Eire | ||
| VA27 | 5-In-1 Vaccine{whooping cough, diphtheria, bacterial meningitis, tetanus and polio} | introduced into the UK in October 2004 | ||
| VA28 | Pneumococcal/Prevenar | from Streptococcus pneumoniae | protective against meningitis, septicaemia, ear infections and pneumonia. Introduced 2000 in US, 2002 in Canada, 2005 in Australia and 2006 in UK; given to children under 5 | |
| VA29 | Cervarix/ HPV Vaccine (Cervical Cancer Vaccination) |
protects against HPV types 16 and 18, but no others. Used in a national immunisation programme in the UK from September 2008. | ||
| VA30 | Gardasil
/ HPV Vaccine (Cervical Cancer Vaccination) |
licensed in over 75 countries, including Britain. It works against HPV types 16, 18, 6 and 11. | ||
| VA31 | H1N1/Swine Flu | (Added to kit December 2009) | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|